Tapewire

Nasdaq · USD

VCEL

Vericel Corp

Export transactions ↓
Tapewire entity
4481
SEC CIK
0000887359
Parsed reports
373

Last 12 months

Inside the activity.

0 purchase rows · 34 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202503
Jan 202601
Feb 202601
Mar 202604
Apr 202601
May 202607
Jun 202609
Jul 202603
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 12, 2026 Filed Aug 14, 2026 20:05 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,000 $0.00 Strike: $13.05 $0.00
Disclosure

SEC source: 0001140361-26-033143 · form4.xml · derivative · entry 3

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,000

Underlying: Common Stock · 7,000 shares

Expires 2028-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 20:05 UTC SaleCommon Stock 7,000 $44.53 $311,710.00
Disclosure

SEC source: 0001140361-26-033143 · form4.xml · nonDerivative · entry 2

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,300

F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 20:05 UTC Exercise / conversionCommon Stock 7,000 $13.05 $91,350.00
Disclosure

SEC source: 0001140361-26-033143 · form4.xml · nonDerivative · entry 1

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:05 UTC
Halpin MichaelChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $16.66 $0.00
Disclosure

SEC source: 0001140361-26-031417 · form4.xml · derivative · entry 3

Halpin Michael · CIK 0001778858 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,250

Underlying: Common Stock · 10,000 shares

Expires 2029-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 76,250 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 6, 2019, which was one quarter after the date on which the option was granted.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:05 UTC
Halpin MichaelChief Operating Officer
SaleCommon Stock 10,000 $46.84 $468,400.00
Disclosure

SEC source: 0001140361-26-031417 · form4.xml · nonDerivative · entry 2

Halpin Michael · CIK 0001778858 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,394

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:05 UTC
Halpin MichaelChief Operating Officer
Exercise / conversionCommon Stock 10,000 $16.66 $166,600.00
Disclosure

SEC source: 0001140361-26-031417 · form4.xml · nonDerivative · entry 1

Halpin Michael · CIK 0001778858 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,394

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 30, 2026 Filed Jul 31, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 500 $0.00 Strike: $29.82 $0.00
Disclosure

SEC source: 0001140361-26-030487 · form4.xml · derivative · entry 9

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 500 shares

Expires 2033-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.

Read SEC document
July 30, 2026 Filed Jul 31, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $29.82 $0.00
Disclosure

SEC source: 0001140361-26-030487 · form4.xml · derivative · entry 8

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 2,500 shares

Expires 2033-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.

Read SEC document
July 30, 2026 Filed Jul 31, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,500 $0.00 Strike: $34.90 $0.00
Disclosure

SEC source: 0001140361-26-030487 · form4.xml · derivative · entry 7

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,698

Underlying: Common Stock · 1,500 shares

Expires 2032-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 4,198 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted

Read SEC document
July 30, 2026 Filed Jul 31, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
SaleCommon Stock 500 $48.90 $24,450.00
Disclosure

SEC source: 0001140361-26-030487 · form4.xml · nonDerivative · entry 6

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,078

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 30, 2026 Filed Jul 31, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
Exercise / conversionCommon Stock 500 $29.82 $14,910.00
Disclosure

SEC source: 0001140361-26-030487 · form4.xml · nonDerivative · entry 5

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,578

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 30, 2026 Filed Jul 31, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
SaleCommon Stock 2,500 $48.90 $122,250.00
Disclosure

SEC source: 0001140361-26-030487 · form4.xml · nonDerivative · entry 4

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,078

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 30, 2026 Filed Jul 31, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
Exercise / conversionCommon Stock 2,500 $29.82 $74,550.00
Disclosure

SEC source: 0001140361-26-030487 · form4.xml · nonDerivative · entry 3

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,578

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 30, 2026 Filed Jul 31, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
SaleCommon Stock 1,500 $48.90 $73,350.00
Disclosure

SEC source: 0001140361-26-030487 · form4.xml · nonDerivative · entry 2

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,078

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 30, 2026 Filed Jul 31, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
Exercise / conversionCommon Stock 1,500 $34.90 $52,350.00
Disclosure

SEC source: 0001140361-26-030487 · form4.xml · nonDerivative · entry 1

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,578

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $29.82 $0.00
Disclosure

SEC source: 0001140361-26-026932 · form4.xml · derivative · entry 4

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 2,500 shares

Expires 2033-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
SaleCommon Stock 2,500 $44.90 $112,250.00
Disclosure

SEC source: 0001140361-26-026932 · form4.xml · nonDerivative · entry 3

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 886

F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
Exercise / conversionCommon Stock 2,500 $29.82 $74,550.00
Disclosure

SEC source: 0001140361-26-026932 · form4.xml · nonDerivative · entry 2

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
SaleCommon Stock 232 $44.90 $10,416.80
Disclosure

SEC source: 0001140361-26-026932 · form4.xml · nonDerivative · entry 1

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 886

F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:05 UTC
Mara Joseph Anthony JrChief Financial Officer
SaleCommon Stock 5,000 $44.75 $223,750.00
Disclosure

SEC source: 0001140361-26-026931 · form4.xml · nonDerivative · entry 1

Mara Joseph Anthony Jr · CIK 0001841148 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,009

F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:05 UTC
Hopper Jonathan MarkChief Medical Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $29.82 $0.00
Disclosure

SEC source: 0001140361-26-026930 · form4.xml · derivative · entry 6

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 5,000 shares

Expires 2033-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 30,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:05 UTC
Hopper Jonathan MarkChief Medical Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $29.82 $0.00
Disclosure

SEC source: 0001140361-26-026930 · form4.xml · derivative · entry 5

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 5,000 shares

Expires 2033-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 30,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:05 UTC
Hopper Jonathan MarkChief Medical Officer
SaleCommon Stock 5,000 $45.00 $225,000.00
Disclosure

SEC source: 0001140361-26-026930 · form4.xml · nonDerivative · entry 4

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,753

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:05 UTC
Hopper Jonathan MarkChief Medical Officer
Exercise / conversionCommon Stock 5,000 $29.82 $149,100.00
Disclosure

SEC source: 0001140361-26-026930 · form4.xml · nonDerivative · entry 3

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,753

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:05 UTC
Hopper Jonathan MarkChief Medical Officer
SaleCommon Stock 5,000 $45.00 $225,000.00
Disclosure

SEC source: 0001140361-26-026930 · form4.xml · nonDerivative · entry 2

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,753

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:05 UTC
Hopper Jonathan MarkChief Medical Officer
Exercise / conversionCommon Stock 5,000 $29.82 $149,100.00
Disclosure

SEC source: 0001140361-26-026930 · form4.xml · nonDerivative · entry 1

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,753

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:05 UTC
Flynn Sean C.Chief Legal Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $16.25 $0.00
Disclosure

SEC source: 0001140361-26-026929 · form4.xml · derivative · entry 3

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 15,000 shares

Expires 2029-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:05 UTC
Flynn Sean C.Chief Legal Officer
SaleCommon Stock 15,000 $45.64 $684,600.00
Disclosure

SEC source: 0001140361-26-026929 · form4.xml · nonDerivative · entry 2

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,647

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 26, 2026 Filed Jun 30, 2026 20:05 UTC
Flynn Sean C.Chief Legal Officer
Exercise / conversionCommon Stock 15,000 $16.25 $243,750.00
Disclosure

SEC source: 0001140361-26-026929 · form4.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,647

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 18, 2026 Filed Jun 22, 2026 20:05 UTC
Halpin MichaelChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $16.66 $0.00
Disclosure

SEC source: 0001140361-26-025952 · form4.xml · derivative · entry 3

Halpin Michael · CIK 0001778858 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,250

Underlying: Common Stock · 10,000 shares

Expires 2029-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 76,250 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 6, 2019, which was one quarter after the date on which the option was granted.

Read SEC document
June 18, 2026 Filed Jun 22, 2026 20:05 UTC
Halpin MichaelChief Operating Officer
SaleCommon Stock 10,000 $40.24 $402,400.00
Disclosure

SEC source: 0001140361-26-025952 · form4.xml · nonDerivative · entry 2

Halpin Michael · CIK 0001778858 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,248

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 18, 2026 Filed Jun 22, 2026 20:05 UTC
Halpin MichaelChief Operating Officer
Exercise / conversionCommon Stock 10,000 $16.66 $166,600.00
Disclosure

SEC source: 0001140361-26-025952 · form4.xml · nonDerivative · entry 1

Halpin Michael · CIK 0001778858 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,248

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 18, 2026 Filed Jun 22, 2026 20:05 UTC
Flynn Sean C.Chief Legal Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $16.25 $0.00
Disclosure

SEC source: 0001140361-26-025951 · form4.xml · derivative · entry 3

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 15,000 shares

Expires 2029-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Read SEC document
June 18, 2026 Filed Jun 22, 2026 20:05 UTC
Flynn Sean C.Chief Legal Officer
SaleCommon Stock 15,000 $40.21 $603,150.00
Disclosure

SEC source: 0001140361-26-025951 · form4.xml · nonDerivative · entry 2

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,647

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 18, 2026 Filed Jun 22, 2026 20:05 UTC
Flynn Sean C.Chief Legal Officer
Exercise / conversionCommon Stock 15,000 $16.25 $243,750.00
Disclosure

SEC source: 0001140361-26-025951 · form4.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,647

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 02, 2026 Filed Jun 4, 2026 20:05 UTC
Hopper Jonathan MarkChief Medical Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 4,375 $0.00 Strike: $16.66 $0.00
Disclosure

SEC source: 0001140361-26-023988 · form4.xml · derivative · entry 3

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,625

Underlying: Common Stock · 4,375 shares

Expires 2029-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 26,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 6, 2019, which was one quarter after the date on which the option was granted.

Read SEC document
June 02, 2026 Filed Jun 4, 2026 20:05 UTC
Hopper Jonathan MarkChief Medical Officer
SaleCommon Stock 4,375 $35.00 $153,125.00
Disclosure

SEC source: 0001140361-26-023988 · form4.xml · nonDerivative · entry 2

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,753

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 02, 2026 Filed Jun 4, 2026 20:05 UTC
Hopper Jonathan MarkChief Medical Officer
Exercise / conversionCommon Stock 4,375 $16.66 $72,887.50
Disclosure

SEC source: 0001140361-26-023988 · form4.xml · nonDerivative · entry 1

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,128

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 13, 2026 Filed May 15, 2026 20:06 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 3,500 $0.00 Strike: $13.05 $0.00
Disclosure

SEC source: 0001140361-26-021656 · form4.xml · derivative · entry 6

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,000

Underlying: Common Stock · 3,500 shares

Expires 2028-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:06 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 3,500 $0.00 Strike: $2.63 $0.00
Disclosure

SEC source: 0001140361-26-021656 · form4.xml · derivative · entry 5

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,500 shares

Expires 2027-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 3, 2017, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:06 UTC SaleCommon Stock 3,500 $32.82 $114,870.00
Disclosure

SEC source: 0001140361-26-021656 · form4.xml · nonDerivative · entry 4

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,300

F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:06 UTC Exercise / conversionCommon Stock 3,500 $13.05 $45,675.00
Disclosure

SEC source: 0001140361-26-021656 · form4.xml · nonDerivative · entry 3

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:06 UTC SaleCommon Stock 3,500 $32.83 $114,905.00
Disclosure

SEC source: 0001140361-26-021656 · form4.xml · nonDerivative · entry 2

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,300

F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.

Read SEC document
May 13, 2026 Filed May 15, 2026 20:06 UTC Exercise / conversionCommon Stock 3,500 $2.63 $9,205.00
Disclosure

SEC source: 0001140361-26-021656 · form4.xml · nonDerivative · entry 1

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:05 UTC SaleCommon Stock 7,500 $32.64 $244,800.00
Disclosure

SEC source: 0001140361-26-021040 · form4.xml · nonDerivative · entry 2

Wotton Paul K · CIK 0001300997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,802

Read SEC document
May 11, 2026 Filed May 13, 2026 20:05 UTC SaleCommon Stock 2,500 $33.05 $82,625.00
Disclosure

SEC source: 0001140361-26-021040 · form4.xml · nonDerivative · entry 1

Wotton Paul K · CIK 0001300997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,302

Read SEC document
May 07, 2026 Filed May 8, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
SaleCommon Stock 1,422 $40.50 $57,591.00
Disclosure

SEC source: 0001140361-26-020030 · form4.xml · nonDerivative · entry 2

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,118

F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 07, 2026 Filed May 8, 2026 20:05 UTC
Mara Joseph Anthony JrChief Financial Officer
SaleCommon Stock 5,000 $40.50 $202,500.00
Disclosure

SEC source: 0001140361-26-020031 · form4.xml · nonDerivative · entry 1

Mara Joseph Anthony Jr · CIK 0001841148 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,009

F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 06, 2026 Filed May 8, 2026 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
SaleCommon Stock 3,433 $38.00 $130,454.00
Disclosure

SEC source: 0001140361-26-020030 · form4.xml · nonDerivative · entry 1

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,540

F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
April 29, 2026 Filed May 1, 2026 20:06 UTC GrantRestricted Stock Unit · Derivative 3,200 $0.00 $0.00
Disclosure

SEC source: 0001140361-26-018544 · form4.xml · derivative · entry 4

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,200

Underlying: Common Stock · 3,200 shares

Expires not disclosed

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F6 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026.

F4 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.